Toll Free: 1-888-928-9744

AiCuris GmbH & Co. KG - Product Pipeline Review - 2015

Published: Mar, 2015 | Pages: 36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

AiCuris GmbH & Co. KG - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'AiCuris GmbH & Co. KG - Product Pipeline Review - 2015', provides an overview of the AiCuris GmbH & Co. KG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AiCuris GmbH & Co. KG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of AiCuris GmbH & Co. KG including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of AiCuris GmbH & Co. KG's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the AiCuris GmbH & Co. KG's pipeline products

Reasons to buy

- Evaluate AiCuris GmbH & Co. KG's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of AiCuris GmbH & Co. KG in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the AiCuris GmbH & Co. KG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of AiCuris GmbH & Co. KG and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of AiCuris GmbH & Co. KG
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of AiCuris GmbH & Co. KG and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of table 4
List of Figures 4
AiCuris GmbH & Co. KG Snapshot 5
AiCuris GmbH & Co. KG Overview 5
Key Information 5
Key Facts 5
AiCuris GmbH & Co. KG - Research and Development Overview 6
Key Therapeutic Areas 6
AiCuris GmbH & Co. KG - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
AiCuris GmbH & Co. KG - Pipeline Products Glance 13
AiCuris GmbH & Co. KG - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
AiCuris GmbH & Co. KG - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
AiCuris GmbH & Co. KG - Drug Profiles 17
pritelivir 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AIC-284 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
AIC-649 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
AIC-277 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AIC-499 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule 1 for Gram-Negative Bacterial Infections 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule 2 for Gram-Negative Bacterial Infections 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule for Bacteral Infections 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule for Gram-Positive Bacterial Infections 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule for Infectious Disease 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule for Viral Infections 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
AiCuris GmbH & Co. KG - Pipeline Analysis 28
AiCuris GmbH & Co. KG - Pipeline Products by Target 28
AiCuris GmbH & Co. KG - Pipeline Products by Route of Administration 29
AiCuris GmbH & Co. KG - Pipeline Products by Molecule Type 30
AiCuris GmbH & Co. KG - Pipeline Products by Mechanism of Action 31
AiCuris GmbH & Co. KG - Recent Pipeline Updates 32
AiCuris GmbH & Co. KG - Dormant Projects 33
AiCuris GmbH & Co. KG - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 35
Disclaimer 36
List of Tables
AiCuris GmbH & Co. KG, Key Information 5
AiCuris GmbH & Co. KG, Key Facts 5
AiCuris GmbH & Co. KG - Pipeline by Indication, 2015 8
AiCuris GmbH & Co. KG - Pipeline by Stage of Development, 2015 9
AiCuris GmbH & Co. KG - Monotherapy Products in Pipeline, 2015 10
AiCuris GmbH & Co. KG - Out-Licensed Products in Pipeline, 2015 11
AiCuris GmbH & Co. KG - Out-Licensed Products/ Combination Treatment Modalities, 2015 12
AiCuris GmbH & Co. KG - Phase II, 2015 13
AiCuris GmbH & Co. KG - Phase I, 2015 14
AiCuris GmbH & Co. KG - Preclinical, 2015 15
AiCuris GmbH & Co. KG - Discovery, 2015 16
AiCuris GmbH & Co. KG - Pipeline by Target, 2015 28
AiCuris GmbH & Co. KG - Pipeline by Route of Administration, 2015 29
AiCuris GmbH & Co. KG - Pipeline by Molecule Type, 2015 30
AiCuris GmbH & Co. KG - Pipeline Products by Mechanism of Action, 2015 31
AiCuris GmbH & Co. KG - Recent Pipeline Updates, 2015 32
AiCuris GmbH & Co. KG - Dormant Developmental Projects,2015 33
AiCuris GmbH & Co. KG, Other Locations 34 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2000
Multi User - US $4000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify